Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

JUSMEDICO ADVOKATANPARTSSELSKAB Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.2% 1.2%   Bankruptcy risk   1.0% 1.3% 1.7% 2.4% 3.4% 1.7% 14.8% 14.5%   Credit score (0-100)   88 81 73 62 54 72 14 15   Credit rating   A A A BBB BBB A BB BB   Credit limit (kDKK)   301.7 45.7 2.7 0.0 0.0 2.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   3,017 3,029 3,145 2,071 1,619 1,518 1,518 1,518   Gross profit   2,161 2,008 2,247 1,388 1,040 984 0.0 0.0   EBITDA   1,100 1,052 757 645 407 729 0.0 0.0   EBIT   1,043 990 702 578 328 676 0.0 0.0   Pre-tax profit (PTP)   1,463.7 974.4 682.9 571.3 320.9 679.7 0.0 0.0   Net earnings   1,139.7 757.5 530.4 443.1 248.6 527.9 0.0 0.0   Pre-tax profit without non-rec. items   1,464 974 683 571 321 680 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   496 416 111 44.5 123 70.2 0.0 0.0   Shareholders equity total   2,881 2,499 1,780 1,692 1,541 1,269 344 344   Interest-bearing liabilities   1,238 15.6 22.9 361 0.0 10.3 0.0 0.0   Balance sheet total (assets)   4,861 3,463 2,811 2,529 1,908 1,628 344 344   Net Debt   -1,736 -1,732 -985 162 -303 -660 -344 -344     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   3,017 3,029 3,145 2,071 1,619 1,518 1,518 1,518   Net sales growth   47.8% 0.4% 3.8% -34.2% -21.9% -6.2% 0.0% 0.0%   Gross profit   2,161 2,008 2,247 1,388 1,040 984 0.0 0.0   Gross profit growth   54.8% -7.1% 11.9% -38.2% -25.1% -5.4% -100.0% 0.0%   Employees   2 2 0 1 1 1 0 0   Employee growth %   100.0% 0.0% -100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,861 3,463 2,811 2,529 1,908 1,628 344 344   Balance sheet change%   -14.6% -28.8% -18.8% -10.0% -24.6% -14.7% -78.9% 0.0%   Added value   1,100.1 1,052.3 757.3 644.7 394.6 728.9 0.0 0.0   Added value %   36.5% 34.7% 24.1% 31.1% 24.4% 48.0% 0.0% 0.0%   Investments   439 -142 -360 -134 -1 -105 -70 0   Net sales trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   36.5% 34.7% 24.1% 31.1% 25.2% 48.0% 0.0% 0.0%   EBIT %   34.6% 32.7% 22.3% 27.9% 20.3% 44.5% 0.0% 0.0%   EBIT to gross profit (%)   48.3% 49.3% 31.3% 41.6% 31.5% 68.7% 0.0% 0.0%   Net Earnings %   37.8% 25.0% 16.9% 21.4% 15.4% 34.8% 0.0% 0.0%   Profit before depreciation and extraordinary items %   39.7% 27.1% 18.6% 24.6% 20.3% 38.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   48.5% 32.2% 21.7% 27.6% 19.8% 44.8% 0.0% 0.0%   ROA %   28.2% 23.8% 22.4% 21.8% 14.8% 38.4% 0.0% 0.0%   ROI %   32.2% 29.5% 32.0% 29.7% 18.0% 47.6% 0.0% 0.0%   ROE %   28.9% 28.2% 24.8% 25.5% 15.4% 37.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   59.3% 72.1% 63.3% 66.9% 80.8% 77.9% 100.0% 100.0%   Relative indebtedness %   64.2% 30.3% 32.1% 39.1% 21.4% 22.8% 0.0% 0.0%   Relative net indebtedness %   -34.3% -27.4% 0.0% 29.5% 2.7% -21.4% -22.6% -22.6%   Net int. bear. debt to EBITDA, %   -157.8% -164.6% -130.0% 25.2% -74.3% -90.5% 0.0% 0.0%   Gearing %   43.0% 0.6% 1.3% 21.3% 0.0% 0.8% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.5% 2.5% 100.7% 5.1% 4.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.2 3.2 2.6 2.9 5.1 4.4 0.0 0.0   Current Ratio   2.2 3.2 2.6 2.9 5.1 4.4 0.0 0.0   Cash and cash equivalent   2,973.7 1,748.0 1,007.7 198.7 302.6 670.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   146.2 128.0 115.4 233.0 261.7 127.5 0.0 0.0   Trade creditors turnover (days)   28.3 24.2 29.4 27.8 29.4 31.0 0.0 0.0   Current assets / Net sales %   141.3% 97.2% 82.5% 114.9% 108.5% 100.5% 22.6% 22.6%   Net working capital   2,324.5 2,024.1 1,585.7 1,570.6 1,411.1 1,181.0 0.0 0.0   Net working capital %   77.0% 66.8% 50.4% 75.8% 87.2% 77.8% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   1,509 1,514 0 2,071 1,619 1,518 0 0   Added value / employee   550 526 0 645 395 729 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   550 526 0 645 407 729 0 0   EBIT / employee   522 495 0 578 328 676 0 0   Net earnings / employee   570 379 0 443 249 528 0 0